Emergency radium RA 223 dichloride - xofigo
Ended Awarded Last action
- Contract number
- 36C24824N0502
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $89,776
Award facts
- Opportunity
-
- 36C24824Q0659 Solicitation number
- Contract value 100% obligated
- $89,775.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,359 | |
| Original award | $97,134 |
About this award
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG. The contract, worth $89,775.53, is for the supply of the radiopharmaceutical medication Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer.
The contract was awarded under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which has a potential value of $840 million. This multiple-award schedule allows various federal agencies to place delivery orders for a wide range of pharmaceutical products. Bayer Healthcare Pharmaceuticals Inc. also holds an $18.2 million Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical for supplying pharmaceuticals and medical supplies.
The contract has no set-aside designation, reflecting Bayer Healthcare Pharmaceuticals Inc.'s status as a large, foreign-owned business. The contract supports critical healthcare needs for military and veteran populations by providing specialized pharmaceutical products to the VA and other federal agencies.
Quick answers
Who was awarded contract 36C24824N0502?
36C24824N0502 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on March 1, 2024.
How much is contract 36C24824N0502 worth?
The government has obligated $89,776 on 36C24824N0502.
Is contract 36C24824N0502 an order under another contract?
Yes. 36C24824N0502 is a delivery order under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24824N0502 competed?
The extent of competition for 36C24824N0502 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award